OneFund LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$182K Sell
609
-59
-9% -$19.4K 0.12% 168
2025
Q4
$234K Buy
668
+37
+6% +$12.5K 0.14% 125
2025
Q3
$204K Buy
631
+21
+3% +$6.53K 0.13% 141
2025
Q2
$237K Sell
610
-3
-0.5% -$1.21K 0.17% 115
2025
Q1
$267K Hold
613
0.27% 93
2024
Q4
$226K Buy
613
+5
+0.8% +$2.09K 0.22% 110
2024
Q3
$316K Sell
608
-5
-0.8% -$2.67K 0.32% 78
2024
Q2
$332K Buy
613
+8
+1% +$4.23K 0.36% 71
2024
Q1
$312K Sell
605
-16
-3% -$7.96K 0.37% 73
2023
Q4
$293K Buy
+621
New +$287K 0.38% 74

Other funds holding ELV

OneFund LLC's ELV Position: Q1 2026 in Review

OneFund LLC reduced its Elevance Health (ELV) stake by 8.8% in Q1 2026, selling an estimated $19.4K and leaving 609 shares worth $182K. The position accounts for 0.12% of the portfolio, ranked #168.

OneFund LLC first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $332K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • OneFund LLC held 609 shares of Elevance Health worth $182K as of Q1 2026.
  • OneFund LLC sold 59 Elevance Health shares in Q1 2026, an estimated $19.4K.
  • Elevance Health made up 0.12% of OneFund LLC's portfolio in Q1 2026, its #168 holding.
  • OneFund LLC first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • OneFund LLC's Elevance Health position peaked at $332K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.